File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Comment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza

TitleComment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza
Authors
Nicholls, JMAschenbrenner, LMPaulson, JCCampbell, ERMalakhov, MPWurtman, DFYu, MFang, F
Issue Date2008
PublisherOxford University Press. The Journal's web site is located at http://jac.oxfordjournals.org/
Citation
Journal Of Antimicrobial Chemotherapy, 2008, v. 62 n. 2, p. 426-428 How to Cite?
DOI: http://dx.doi.org/10.1093/jac/dkn167
Persistent Identifierhttp://hdl.handle.net/10722/148571
ISSN
0305-7453
2023 Impact Factor: 3.9
2023 SCImago Journal Rankings: 1.271
ISI Accession Number ID
WOS:000257578200033
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorNicholls, JMen_US
dc.contributor.authorAschenbrenner, LMen_US
dc.contributor.authorPaulson, JCen_US
dc.contributor.authorCampbell, ERen_US
dc.contributor.authorMalakhov, MPen_US
dc.contributor.authorWurtman, DFen_US
dc.contributor.authorYu, Men_US
dc.contributor.authorFang, Fen_US
dc.date.accessioned2012-05-29T06:13:48Z-
dc.date.available2012-05-29T06:13:48Z-
dc.date.issued2008en_US
dc.identifier.citationJournal Of Antimicrobial Chemotherapy, 2008, v. 62 n. 2, p. 426-428en_US
dc.identifier.issn0305-7453en_US
dc.identifier.urihttp://hdl.handle.net/10722/148571-
dc.languageengen_US
dc.publisherOxford University Press. The Journal's web site is located at http://jac.oxfordjournals.org/en_US
dc.relation.ispartofJournal of Antimicrobial Chemotherapyen_US
dc.subject.meshAntiviral Agents - Pharmacology - Therapeutic Useen_US
dc.subject.meshBacterial Adhesionen_US
dc.subject.meshDisease Outbreaks - Prevention & Controlen_US
dc.subject.meshHumansen_US
dc.subject.meshInfluenza, Human - Prevention & Controlen_US
dc.subject.meshLectins - Metabolismen_US
dc.subject.meshNeuraminidase - Pharmacology - Therapeutic Useen_US
dc.subject.meshPneumococcal Infectionsen_US
dc.subject.meshRecombinant Proteins - Pharmacology - Therapeutic Useen_US
dc.subject.meshRespiratory Mucosa - Chemistryen_US
dc.subject.meshStreptococcus Pneumoniae - Physiologyen_US
dc.titleComment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenzaen_US
dc.typeArticleen_US
dc.identifier.emailNicholls, JM:nicholls@pathology.hku.hken_US
dc.identifier.authorityNicholls, JM=rp00364en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1093/jac/dkn167en_US
dc.identifier.pmid18434340-
dc.identifier.scopuseid_2-s2.0-47249119786en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-47249119786&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume62en_US
dc.identifier.issue2en_US
dc.identifier.spage426en_US
dc.identifier.epage428en_US
dc.identifier.isiWOS:000257578200033-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.issnl0305-7453-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats